Visual field loss and accelerometer-measured physical activity in the United States

Suzanne W. Van Landingham, Jeffrey R. Willis, Susan Vitale, Pradeep Ramulu

Research output: Contribution to journalArticle

Abstract

Objective: To determine whether visual field (VF) loss is associated with lower levels of accelerometer-defined walking or physical activity in a nationally representative sample of American adults. Design: Cross-sectional study. Participants: A total of 2934 adults aged 40 years or older who participated in the examination component of the 2005-2006 National Health and Nutritional Examination Survey. Methods: Frequency-doubling technology (FDT) testing was performed in both eyes and used to categorize subjects as having no VF loss, unilateral VF loss, or bilateral VF loss. Accelerometer data were collected over 7 days of normal activity. Main Outcome Measures: Steps per day and daily minutes of moderate or vigorous physical activity (MVPA). Results: A total of 1468 participants (50.0%) had complete FDT and accelerometer data. Individuals without VF loss averaged 9751 steps/day and 20.8 minutes/day of MVPA, compared with 8023 steps/day and 14.5 minutes/day for subjects with unilateral VF loss (age-adjusted P = 0.11 and P = 0.51) and 6840 steps/day and 10.1 minutes/day for subjects with bilateral VF loss (age-adjusted P = 0.02 and 0.09, respectively). In multivariable models adjusted for age, sex, race/ethnicity, education, and several comorbid illnesses, individuals with bilateral VF loss took 17% fewer steps per day (P <0.01) and engaged in 30% less MVPA (P = 0.02) than individuals without VF loss. No significant difference in steps per day or MVPA was observed between individuals with unilateral VF loss and no VF loss (P > 0.05). In addition to VF loss, older age, female sex, arthritis, diabetes, congestive heart failure (CHF), and stroke were significantly associated with fewer daily steps and minutes of MVPA (P <0.05). Conclusions: Bilateral VF loss is associated with less walking and physical activity in American adults. Patients with bilateral VF loss should be encouraged to engage safely in more physical activity. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Original languageEnglish (US)
Pages (from-to)2486-2492
Number of pages7
JournalOphthalmology
Volume119
Issue number12
DOIs
StatePublished - Dec 2012

Fingerprint

Visual Fields
Exercise
Walking
Technology
Nutrition Surveys
Disclosure
Arthritis
Heart Failure
Cross-Sectional Studies
Stroke
Outcome Assessment (Health Care)
Education

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Visual field loss and accelerometer-measured physical activity in the United States. / Van Landingham, Suzanne W.; Willis, Jeffrey R.; Vitale, Susan; Ramulu, Pradeep.

In: Ophthalmology, Vol. 119, No. 12, 12.2012, p. 2486-2492.

Research output: Contribution to journalArticle

Van Landingham, Suzanne W. ; Willis, Jeffrey R. ; Vitale, Susan ; Ramulu, Pradeep. / Visual field loss and accelerometer-measured physical activity in the United States. In: Ophthalmology. 2012 ; Vol. 119, No. 12. pp. 2486-2492.
@article{1ce458deb18640729615b41f6a11e9f1,
title = "Visual field loss and accelerometer-measured physical activity in the United States",
abstract = "Objective: To determine whether visual field (VF) loss is associated with lower levels of accelerometer-defined walking or physical activity in a nationally representative sample of American adults. Design: Cross-sectional study. Participants: A total of 2934 adults aged 40 years or older who participated in the examination component of the 2005-2006 National Health and Nutritional Examination Survey. Methods: Frequency-doubling technology (FDT) testing was performed in both eyes and used to categorize subjects as having no VF loss, unilateral VF loss, or bilateral VF loss. Accelerometer data were collected over 7 days of normal activity. Main Outcome Measures: Steps per day and daily minutes of moderate or vigorous physical activity (MVPA). Results: A total of 1468 participants (50.0{\%}) had complete FDT and accelerometer data. Individuals without VF loss averaged 9751 steps/day and 20.8 minutes/day of MVPA, compared with 8023 steps/day and 14.5 minutes/day for subjects with unilateral VF loss (age-adjusted P = 0.11 and P = 0.51) and 6840 steps/day and 10.1 minutes/day for subjects with bilateral VF loss (age-adjusted P = 0.02 and 0.09, respectively). In multivariable models adjusted for age, sex, race/ethnicity, education, and several comorbid illnesses, individuals with bilateral VF loss took 17{\%} fewer steps per day (P <0.01) and engaged in 30{\%} less MVPA (P = 0.02) than individuals without VF loss. No significant difference in steps per day or MVPA was observed between individuals with unilateral VF loss and no VF loss (P > 0.05). In addition to VF loss, older age, female sex, arthritis, diabetes, congestive heart failure (CHF), and stroke were significantly associated with fewer daily steps and minutes of MVPA (P <0.05). Conclusions: Bilateral VF loss is associated with less walking and physical activity in American adults. Patients with bilateral VF loss should be encouraged to engage safely in more physical activity. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.",
author = "{Van Landingham}, {Suzanne W.} and Willis, {Jeffrey R.} and Susan Vitale and Pradeep Ramulu",
year = "2012",
month = "12",
doi = "10.1016/j.ophtha.2012.06.034",
language = "English (US)",
volume = "119",
pages = "2486--2492",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Visual field loss and accelerometer-measured physical activity in the United States

AU - Van Landingham, Suzanne W.

AU - Willis, Jeffrey R.

AU - Vitale, Susan

AU - Ramulu, Pradeep

PY - 2012/12

Y1 - 2012/12

N2 - Objective: To determine whether visual field (VF) loss is associated with lower levels of accelerometer-defined walking or physical activity in a nationally representative sample of American adults. Design: Cross-sectional study. Participants: A total of 2934 adults aged 40 years or older who participated in the examination component of the 2005-2006 National Health and Nutritional Examination Survey. Methods: Frequency-doubling technology (FDT) testing was performed in both eyes and used to categorize subjects as having no VF loss, unilateral VF loss, or bilateral VF loss. Accelerometer data were collected over 7 days of normal activity. Main Outcome Measures: Steps per day and daily minutes of moderate or vigorous physical activity (MVPA). Results: A total of 1468 participants (50.0%) had complete FDT and accelerometer data. Individuals without VF loss averaged 9751 steps/day and 20.8 minutes/day of MVPA, compared with 8023 steps/day and 14.5 minutes/day for subjects with unilateral VF loss (age-adjusted P = 0.11 and P = 0.51) and 6840 steps/day and 10.1 minutes/day for subjects with bilateral VF loss (age-adjusted P = 0.02 and 0.09, respectively). In multivariable models adjusted for age, sex, race/ethnicity, education, and several comorbid illnesses, individuals with bilateral VF loss took 17% fewer steps per day (P <0.01) and engaged in 30% less MVPA (P = 0.02) than individuals without VF loss. No significant difference in steps per day or MVPA was observed between individuals with unilateral VF loss and no VF loss (P > 0.05). In addition to VF loss, older age, female sex, arthritis, diabetes, congestive heart failure (CHF), and stroke were significantly associated with fewer daily steps and minutes of MVPA (P <0.05). Conclusions: Bilateral VF loss is associated with less walking and physical activity in American adults. Patients with bilateral VF loss should be encouraged to engage safely in more physical activity. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

AB - Objective: To determine whether visual field (VF) loss is associated with lower levels of accelerometer-defined walking or physical activity in a nationally representative sample of American adults. Design: Cross-sectional study. Participants: A total of 2934 adults aged 40 years or older who participated in the examination component of the 2005-2006 National Health and Nutritional Examination Survey. Methods: Frequency-doubling technology (FDT) testing was performed in both eyes and used to categorize subjects as having no VF loss, unilateral VF loss, or bilateral VF loss. Accelerometer data were collected over 7 days of normal activity. Main Outcome Measures: Steps per day and daily minutes of moderate or vigorous physical activity (MVPA). Results: A total of 1468 participants (50.0%) had complete FDT and accelerometer data. Individuals without VF loss averaged 9751 steps/day and 20.8 minutes/day of MVPA, compared with 8023 steps/day and 14.5 minutes/day for subjects with unilateral VF loss (age-adjusted P = 0.11 and P = 0.51) and 6840 steps/day and 10.1 minutes/day for subjects with bilateral VF loss (age-adjusted P = 0.02 and 0.09, respectively). In multivariable models adjusted for age, sex, race/ethnicity, education, and several comorbid illnesses, individuals with bilateral VF loss took 17% fewer steps per day (P <0.01) and engaged in 30% less MVPA (P = 0.02) than individuals without VF loss. No significant difference in steps per day or MVPA was observed between individuals with unilateral VF loss and no VF loss (P > 0.05). In addition to VF loss, older age, female sex, arthritis, diabetes, congestive heart failure (CHF), and stroke were significantly associated with fewer daily steps and minutes of MVPA (P <0.05). Conclusions: Bilateral VF loss is associated with less walking and physical activity in American adults. Patients with bilateral VF loss should be encouraged to engage safely in more physical activity. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=84870706169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870706169&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2012.06.034

DO - 10.1016/j.ophtha.2012.06.034

M3 - Article

C2 - 22892152

AN - SCOPUS:84870706169

VL - 119

SP - 2486

EP - 2492

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 12

ER -